Leonora Culp1, Sara Moradi Tuchayi2, Hossein Alinia1, Steven R Feldman3. 1. Center for Dermatology Research, Departments of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA. 2. Center for Dermatology Research, Departments of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA smoradit@wakehealth.edu. 3. Center for Dermatology Research, Departments of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA Departments of Pathology and Wake Forest School of Medicine, Winston-Salem, NC, USA Departments of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Abstract
BACKGROUND: Topical retinoids are first-line treatment options for acne vulgaris. These drugs, however, produce varying degree of cutaneous irritation within the first few weeks of treatment. OBJECTIVE: Our purpose was to examine differences in tolerability of topical retinoids and assess whether these differences would be clinically meaningful. METHODS: A PubMed search was performed for sources on topical retinoids in acne vulgaris treatment. Thirty-four clinical studies were analyzed. RESULTS: Thirteen studies had statistically significant results on tolerability of retinoid based on retinoid, vehicle, concentration, or skin type. All studies classified most of skin reactions as mild-moderate. Large differences in the number of dropouts due to irritation were not identified. CONCLUSION: Irritation studies did not show a high frequency of clinically significant irritation with topical retinoids. We anticipate that the large variation in patient use of topical retinoids would likely account for more variation in response than differences between drug formulations.
BACKGROUND: Topical retinoids are first-line treatment options for acne vulgaris. These drugs, however, produce varying degree of cutaneous irritation within the first few weeks of treatment. OBJECTIVE: Our purpose was to examine differences in tolerability of topical retinoids and assess whether these differences would be clinically meaningful. METHODS: A PubMed search was performed for sources on topical retinoids in acne vulgaris treatment. Thirty-four clinical studies were analyzed. RESULTS: Thirteen studies had statistically significant results on tolerability of retinoid based on retinoid, vehicle, concentration, or skin type. All studies classified most of skin reactions as mild-moderate. Large differences in the number of dropouts due to irritation were not identified. CONCLUSION:Irritation studies did not show a high frequency of clinically significant irritation with topical retinoids. We anticipate that the large variation in patient use of topical retinoids would likely account for more variation in response than differences between drug formulations.
Authors: Hilary Baldwin; Guy Webster; Linda Stein Gold; Valerie Callender; Fran E Cook-Bolden; Eric Guenin Journal: Am J Clin Dermatol Date: 2021-05 Impact factor: 7.403
Authors: Lawrence F Eichenfield; Jeffrey L Sugarman; Eric Guenin; Susan Harris; Varsha Bhatt Journal: Pediatr Dermatol Date: 2019-01-18 Impact factor: 1.588
Authors: U Blume-Peytavi; J Fowler; L Kemény; Z Draelos; F Cook-Bolden; T Dirschka; L Eichenfield; M Graeber; F Ahmad; A Alió Saenz; P Rich; E Tanghetti Journal: J Eur Acad Dermatol Venereol Date: 2019-08-20 Impact factor: 6.166
Authors: Linda Stein Gold; Hilary Baldwin; Leon H Kircik; Jonathan S Weiss; David M Pariser; Valerie Callender; Edward Lain; Michael Gold; Kenneth Beer; Zoe Draelos; Neil Sadick; Radhakrishnan Pillai; Varsha Bhatt; Emil A Tanghetti Journal: Am J Clin Dermatol Date: 2021-10-21 Impact factor: 7.403